Cryoport (CYRX) Misses Q2 EPS by 19c; Offers FY23 Revenue Guidance
Cryoport (NASDAQ: CYRX) reported Q2 EPS of ($0.42), $0.19 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $57 million versus the consensus estimate of $68.81 million.
GUIDANCE:
Cryoport sees FY2023 revenue of $233-243 million, versus the consensus of $243 million.
For earnings history and earnings-related data on Cryoport (CYRX) click here.
